ArticleFrontiers in cellular and infection microbiology2025

Postoperative hepatitis B virus reactivation and its impact on survival in HBV-related hepatocellular carcinoma patients undergoing conversion therapy with interventional therapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors.

Shaowei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.